Imatinib Mesylate from Canada
Imatinib mesylate, tyrosine kinase inhibitor with pyrimidine and piperazine rings (N hetero-atoms only), used in leukemia treatment. HTS 2933.99.8290 for bulk API as other aromatic heterocyclic nitrogen compounds. Key oncology pharmaceutical intermediate.
Duty Rate — Canada → United States
110%
Rate breakdown
9903.04.6093.5%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.2910%Except for products described in headings 9903.05.85–9903.05.93, articles the product of Canada, as provided for in U.S. note 52 to this subchapter
Import Tips
• Include DEA import permit if precursor status applies
• Specify crystalline form (polymorph B typically) in COA
• Provide stability data for transport conditions